Carbonic Anhydrase Ix Inhibitors in Cancer Therapy: An Update

References

• Supuran CT . Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov.7 (2), 168–181 (2008).
   PubMed Web of Science ®Google Scholar
• Pastorekova S , SupuranCT. Carbonic anhydrase IX: from biology to therapy. In : Hypoxia and Cancer. MelilloG ( Ed.). Humana Press, Springer Science+Business Mediam, NY, USA, 121–153 (2014).
   Google Scholar
• Neri D , SupuranCT. Interfering with pH regulation in tumors as a therapeutic strategy. Nat. Rev. Drug Discov.10 (10), 767–77 (2011).
   PubMed Web of Science ®Google Scholar
• McDonald PC , WinumJY, SupuranCTet al. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget3 (1), 84–97 (2012).
   PubMed Web of Science ®Google Scholar
• Zatovicova M , JelenskaL, HulikovaAet al. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr. Pharm. Des.16 (29), 3255–3263 (2010).
   PubMed Web of Science ®Google Scholar
• Monti SM , SupuranCT, De SimoneG. Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013). Expert Opin. Ther. Pat.23 (6), 737–749 (2013).
   PubMed Web of Science ®Google Scholar
• Poulsen SA . Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007–2009. Expert Opin. Ther. Pat.20 (6), 795–806 (2010).
   PubMed Web of Science ®Google Scholar
• Winum JY , RamiM, ScozzafavaA, MonteroJLet al. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med. Res. Rev.28 (3), 445–463 (2008).
   PubMed Web of Science ®Google Scholar
• Supuran CT . Structure-based drug discovery of carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem.27 (6), 759–772 (2012).
   PubMed Web of Science ®Google Scholar
• Winum JY , ColinasPA, SupuranCT. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer. Bioorg. Med. Chem.21 (6), 1419–1426 (2013).
   PubMed Web of Science ®Google Scholar
• Stiti M , CecchiA, RamiMet al. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. J. Am. Chem. Soc.130 (48), 16130–1611 (2008).
   PubMed Web of Science ®Google Scholar
• Ratto F , WitortE, TatiniFet al. Plasmonic particles that hit hypoxic cells Adv. Funct. Mater. 25 (2), 316–323 (2015).
   Web of Science ®Google Scholar
• Winum JY . Carbonic anhydrase inhibitors: CA IX selective inhibitors incorporating aromatic or heterocyclic sulfonamide. Expert Opin. Ther. Pat.15 (2), 233–236 (2005).
   Web of Science ®Google Scholar
• Dubois L , LieuwesNG, MarescaAet al. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re), -oxygenated cells in a xenograft tumour model. Radiother. Oncol.92 (3), 423–428 (2009).
   PubMed Web of Science ®Google Scholar
• Winum JY . Carbonic anhydrase IX inhibitors: fluorescent sulfonamides as therapeutic and diagnostic agents. Expert Opin. Ther. Pat.17 (11), 1393–1396 (2007).
   Web of Science ®Google Scholar
• Cecchi A , HulikovaA, PastorekJet al. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J. Med. Chem.48 (15), 4834–4841 (2005).
   PubMed Web of Science ®Google Scholar
• Svastová E , HulíkováA, RafajováMet al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett.577 (3), 439–445 (2004).
   PubMed Web of Science ®Google Scholar
• Dubois L , DoumaK, SupuranCTet al. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Radiother. Oncol.83 (3), 367–373 (2007).
   PubMed Web of Science ®Google Scholar
• Akurathi V , DuboisL, CelenSet al. Development and biological evaluation of 99mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers. Eur. J Med. Chem.71, 374–384 (2014).
   PubMed Web of Science ®Google Scholar
• Akurathi V , DuboisL, LieuwesNGet al. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia. Nucl. Med. Biol.37 (5), 557–564 (2010).
   PubMed Web of Science ®Google Scholar
• Teicher BA , LiuSD, LiuJTet al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res.13 (5A), 1549–1556 (1993).
   PubMed Web of Science ®Google Scholar
• Chegwidden WR , SpencerIM. Sulphonamide inhibitors of carbonic anhydrase inhibit the growth of human lymphoma cells in culture. Inflammopharmacology3 (3), 231–239 (1995).
   Google Scholar
• Supuran CT , ScozzafavaA. Carbonic anhydrase inhibitors – Part 94. 1,3,4-thiadiazole-2-sulfonamidederivatives as antitumor agents?Eur. J. Med. Chem.35 (9), 867–874 (2000).
   PubMed Web of Science ®Google Scholar
• Supuran CT , BrigantiF, TilliSet al. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg. Med. Chem. 9 (3), 703–714 (2001).
   PubMed Web of Science ®Google Scholar
• Ahlskog JK , DumelinCE, TrüsselSet al. in vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. Bioorg. Med. Chem. Lett.19 (16), 4851–4856 (2009).
   PubMed Web of Science ®Google Scholar
• Buller F , SteinerM, FreyKet al. Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds. ACS Chem. Biol.6 (4), 336–344 (2011).
   PubMed Web of Science ®Google Scholar
• Franzini RM , NeriD, ScheuermannJ. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries. Acc. Chem. Res.47 (4), 1247–1255 (2014).
   PubMed Web of Science ®Google Scholar
• Pacchiano F , CartaF, McDonaldPCet al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J. Med. Chem.54 (6), 1896–1902 (2011).
   PubMed Web of Science ®Google Scholar
• Lou Y , McDonaldPC, OloumiAet al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res.71 (9), 3364–3376 (2011).
   PubMed Web of Science ®Google Scholar
• Lock FE , McDonaldPC, LouYet al. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene32 (44), 5210–5219 (2013).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials Database: NCT02215850 https://clinicaltrials.gov/ct2/show/NCT02215850.
   Google Scholar
• Winum JY , CartaF, WardCet al. Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines. Bioorg. Med. Chem. Lett.22 (14), 4681–4685 (2012).
   PubMed Web of Science ®Google Scholar
• Gieling RG , BaburM, MamnaniLet al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J. Med. Chem.55 (11), 5591–5600 (2012).
   PubMed Web of Science ®Google Scholar
• Dubois L , PeetersS, LieuwesNGet al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother. Oncol.99 (3), 424–431 (2011).
   PubMed Web of Science ®Google Scholar
• Rami M , DuboisL, ParvathaneniNKet al. Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates. J. Med. Chem.56 (21), 8512–8520 (2013).
   PubMed Web of Science ®Google Scholar
• Dubois L , PeetersSG, van KuijkSJet al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother. Oncol.108 (3), 523–528 (2013).
   PubMed Web of Science ®Google Scholar
• Krall N , PrettoF, DecurtinsWet al. A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. Angew. Chem. Int. Ed. Engl.53 (16), 4231–4235 (2014).
   PubMed Web of Science ®Google Scholar
• Touisni N , MarescaA, McDonaldPCet al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J. Med. Chem.54 (24), 8271–8277 (2011).
   PubMed Web of Science ®Google Scholar